Potential Personalized Therapy For Asthma And COPD

Researchers at Washington University School of Medicine in St. Louis have defined a new type of immune response that is activated in patients with severe asthma and COPD (chronic obstructive pulmonary disease). Their discovery could dramatically improve diagnosis and treatment of patients with chronic inflammatory lung disease.

More: continued here

Filed under: Immune System / Vaccines on May 22nd, 2008